北京老年髋部骨折多学科共管项目的成本效果分析
该研究评估北京某骨科医院老年髋部骨折多学科共管项目相较常规管理的成本效果,采用Markov微观模拟模型模拟终身成本和效果。结果显示干预组终身成本更高但QALY略增,增量成本效果比为每QALY 19,437美元,在中国支付意愿阈值下具有78%的成本效果概率。
要点
- 多学科共管项目在中国老年髋部骨折人群中具有成本效果。
- 增量成本效果比为每QALY 19,437美元,低于中国WTP阈值。
- 成本效果对干预成本和48小时内手术比例敏感。
核心结论
- 老年髋部骨折多学科共管项目在中国人群中具有成本效果,具备推广潜力。
研究设计与样本
- 基于北京某骨科医院髋部骨折患者,构建Markov微观模拟模型模拟终身成本和效果,干预组n=1192,常规管理组n=1839,采用医疗保健视角,成本和效果按每年5%贴现。
主要发现
- 常规管理组和干预组的终身成本分别为11,975美元和13,309美元。
- 常规管理组和干预组的终身QALY分别为2.38年和2.45年。
- 常规管理组和干预组的第一年死亡率分别为17.8%和16.1%。
- 增量成本效果比为每QALY 19,437美元或每避免1年死亡78,412美元。
- 在中国WTP阈值(每QALY 26,481美元)下,干预具有78%的成本效果概率。
关键数值与推荐
- 支付意愿阈值设定为每QALY 26,481美元,即中国人均GDP的三倍。
- 成本效果对干预成本和48小时内手术患者比例敏感。
临床怎么用
- 在中国医疗体系中可考虑推广老年髋部骨折多学科共管模式以改善成本效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The multidisciplinary co-management program for geriatric patients with hip fracture is cost-effective in the Chinese population and it has the potential to be scaled up in China. INTRODUCTION: The study aimed to investigate the cost-effectiveness of a multidisciplinary co-management program for patients with hip fracture in China. METHODS: Hip fracture patients who were admitted to an orthopedic hospital in Beijing were included in the multidisciplinary co-management program. The cost-effectiveness of intervention was evaluated compared to the conventional management. A Markov microsimulation model was developed to simulate lifetime costs and effectiveness. Costs including intervention, hospitalization, medications, and long-term care costs were expressed using 2019 US dollars and the healthcare perspective was adopted. Effectiveness was evaluated using both 1-year mortality-averted and quality-adjusted life years (QALYs). Costs and effectiveness were discounted at 5% per annum. The willingness-to-pay (WTP) threshold was set at $26,481 per QALY gained which was three times gross domestic product (GDP) per capita in China. One-way and probabilistic sensitivity analyses were conducted. RESULTS: The lifetime cost for the conventional management (n = 1839) and intervention group (n = 1192) was $11,975 and $13,309 respectively. The lifetime QALYs were 2.38 and 2.45 years and the first-year mortality was 17.8% and 16.1%. The incremental cost-effectiveness ratio was $19,437 per QALY gained or $78,412 per 1-year mortality-averted. Given the Chinese WTP threshold, the intervention had a 78% chance being cost-effective. The cost-effectiveness of the intervention was sensitive to cost of intervention and the proportion of patients who underwent surgery within 48 h. CONCLUSIONS: The multidisciplinary co-management program for patients with hip fracture is cost-effective and it has the potential to be scaled up in the Chinese population.
引用
- Peng K, Yang M, Tian M, et al. Cost-effectiveness of a multidisciplinary co-management program for the older hip fracture patients in Beijing. Osteoporos Int. 2020. PMID: 32219498. doi:10.1007/s00198-020-05393-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。